Australia's imaging expenditure artificially inflated?
This article was originally published in Clinica
Executive Summary
High growth rates in expenditure on diagnostic imaging services under Australia's Medicare system are "artificially inflated", argues Dr Peter Duffy of the Royal Australian College of Radiologists. Taking into account cost-shifting by hospitals from state to federal government budgets and demographic changes, use of these services has actually declined over the past five years, he believes.
You may also be interested in...
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Stakeholders Devise Six-Point Plan To Improve Cross-Border Clinical Trials
Sponsors need guidance on ethics requirements and clarity around national regulations to conduct cross-border clinical trials in the EU, a multi-stakeholder forum says.